President Trump’s threat to raise tariffs on automobiles was probably an attempt to speed up ratification of the U.S./EU trade deal negotiated in August last year.
The Musk v. Altman trial tests whether OpenAI’s for‑profit shift was legal — a ruling that could reshape how AI labs raise capital, structure governance and attract investors.
Big Tech’s $725 billion AI spend has a new bottleneck. Here’s what the capex explosion tells us about artificial intelligence’s real constraint.
How to generate excitement and demand for a new credit card? A big Silicon Valley fintech is leaning into crypto.
What do experts expect for Microsoft stock in 2026? Read this analysis of MSFT’s growth trends and analyst price targets for the 2026 fiscal year to get a better idea.
New JAMA studies examine whether routine colonoscopies and low‑dose thyroid drugs benefit older adults, raising questions about risks, costs and continued use.
European automakers are under pressure and need restructuring. But global turmoil offers relief; increased defense spending presents a potentially lucrative lifeline.
Trump promises maximum consumer choice in health care. Yet, he is making it harder to access home -based care favored by older adults and young people with disabilities.
China’s BYD suffered a rare setback last year when its earnings fell nearly 20%, but Europe remains a prime target.
The San Francisco fintech announced a new set of rewards–including cash back on one category of spending–in a bid to boost new-user growth.